Vigabatrin and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vigabatrin (vigabatrin) and Pulmicort (budesonide). Common drug interactions include seizure among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Vigabatrin and Pulmicort. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Vigabatrin?

Vigabatrin has active ingredients of vigabatrin. eHealthMe is studying from 4,046 Vigabatrin users. Check the latest studies of Vigabatrin.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.



On Aug, 08, 2026

26 people who take Vigabatrin and Pulmicort together, and have interactions are studied.

Vigabatrin and Pulmicort drug interactions.

What are the common drug interactions of Vigabatrin and Pulmicort, by gender? *:

female:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Cough
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  5. Carbon dioxide increased
  6. Dyspnoea (difficult or laboured respiration)
  7. Influenza
  8. Pneumonia
  9. Pneumonia influenzal (the flu with pneumonia)
  10. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

male:

  1. Pneumonia
  2. Constipation
  3. Dyspepsia (indigestion)
  4. Oral discharge
  5. Adverse event
  6. Upper respiratory tract inflammation
  7. Hospitalisation
  8. Hypersensitivity
  9. Lung infection
  10. Pyrexia (fever)

What are the common drug interactions of Vigabatrin and Pulmicort, by age (0-1 to 60+)? *:

0-1:

  1. Cough
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  4. Lung infection
  5. Pneumonia
  6. Pyrexia (fever)
  7. Vomiting

2-9:

  1. Constipation
  2. Dyspepsia (indigestion)
  3. Pneumonia influenzal (the flu with pneumonia)
  4. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  5. Tracheitis (an inflammation of the trachea)
  6. Oral discharge
  7. Pneumonia
  8. Upper respiratory tract inflammation
  9. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  10. Adverse event

10-19:

  1. Renal failure (kidney dysfunction)
  2. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Infantile Spasms: 11 people, 42.31%
  2. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 9 people, 34.62%
  3. Gastrointestinal Motility Disorder (abnormal intestinal contractions): 3 people, 11.54%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Vigabatrin and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vigabatrin and Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vigabatrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vigabatrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pulmicort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vigabatrin and budesonide (the active ingredients of Vigabatrin and Pulmicort, respectively), and Vigabatrin and Pulmicort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: